Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2007 or most recent year available [see all tables in this series...]

Part (i) All clients by country and primary drug and type of treatment unit

Country		Amphetamines		MDMA and other derivatives
		Outpatient	Inpatient	Outpatient	Inpatient
Belgium	(1)	283	189	36	14
Bulgaria		5	5	0	0
Czech Republic		956	1187	1	1
Denmark		352	29	34	5
Germany	(2)	:	:	:	:
Estonia		:	:	:	:
Ireland		26	9	104	19
Greece		0	0	2	2
Spain	(3)	426	:	165	:
France		66	0	136	1
Italy		49	:	151	:
Cyprus		0	0	9	0
Latvia	(4)	:	124	:	0
Lithuania	(2)	:	:	:	:
Luxembourg		1	0	7	3
Hungary	(5)	433	:	73	:
Malta	(6)	0	:	19	:
Netherlands	(7)	513	:	115	:
Austria		65	23	30	2
Poland		:	:	:	:
Portugal	(8)		:		:
Romania		0	2	6	17
Slovenia		0	:	1	:
Slovakia		213	162	6	0
Finland		282	217	3	4
Sweden		494	1131	9	7
Uk		4499	74	883	10
Croatia		219	15	114	7
Turkey		:	0	:	91
Norway		:	:	:	:

Notes:

 : indicates data not available 

 (1) Last data available refer to 2005.   

 (2) Only aggregated data for stimulants (other than cocaine) are available. Germany reported 2677 clients (outpatient) and 628 clients (inpatients). Lithuania 146 clients (outpatient).   

 (3) Last data available refer to 2006.   

 (4) Data for overall number of clients are reported only for inpatient centres.   

 (5) Data refer to outpatient and inpatient centres (aggregated data).   

 (6) Last data available refer to 2006.   

 (7) Data refer to outpatient centres and low-threshold agencies (aggregated data). 

 (8) Portugal has reported 4 new clients (Amphetamines) and 9 new clients (MDMA) in outpatient centres. 

 The number of treatment clients in each country is listed in Table TDI-7. 

 See also 'General notes for interpreting data’ on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2008 — TDI. See Table TDI-0 for details on sources. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)